Chapter/Section Purchase

1 Study Coverage
1.1 Vitamin K Antagonists (VKA) Product Introduction
1.2 Market by Type
1.2.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Vitamin K Antagonists
1.2.3 Injection Vitamin K Antagonists
1.3 Market by Application
1.3.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vitamin K Antagonists (VKA) Sales Estimates and Forecasts 2017-2028
2.2 Global Vitamin K Antagonists (VKA) Revenue Estimates and Forecasts 2017-2028
2.3 Global Vitamin K Antagonists (VKA) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vitamin K Antagonists (VKA) Sales by Region
2.4.1 Global Vitamin K Antagonists (VKA) Sales by Region (2017-2022)
2.4.2 Global Sales Vitamin K Antagonists (VKA) by Region (2023-2028)
2.5 Global Vitamin K Antagonists (VKA) Revenue by Region
2.5.1 Global Vitamin K Antagonists (VKA) Revenue by Region (2017-2022)
2.5.2 Global Vitamin K Antagonists (VKA) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vitamin K Antagonists (VKA) Sales by Manufacturers
3.1.1 Global Top Vitamin K Antagonists (VKA) Manufacturers by Sales (2017-2022)
3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vitamin K Antagonists (VKA) in 2021
3.2 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers
3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers (2017-2022)
3.2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vitamin K Antagonists (VKA) Revenue in 2021
3.3 Global Vitamin K Antagonists (VKA) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vitamin K Antagonists (VKA) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vitamin K Antagonists (VKA) Sales by Type
4.1.1 Global Vitamin K Antagonists (VKA) Historical Sales by Type (2017-2022)
4.1.2 Global Vitamin K Antagonists (VKA) Forecasted Sales by Type (2023-2028)
4.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2028)
4.2 Global Vitamin K Antagonists (VKA) Revenue by Type
4.2.1 Global Vitamin K Antagonists (VKA) Historical Revenue by Type (2017-2022)
4.2.2 Global Vitamin K Antagonists (VKA) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2028)
4.3 Global Vitamin K Antagonists (VKA) Price by Type
4.3.1 Global Vitamin K Antagonists (VKA) Price by Type (2017-2022)
4.3.2 Global Vitamin K Antagonists (VKA) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vitamin K Antagonists (VKA) Sales by Application
5.1.1 Global Vitamin K Antagonists (VKA) Historical Sales by Application (2017-2022)
5.1.2 Global Vitamin K Antagonists (VKA) Forecasted Sales by Application (2023-2028)
5.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2028)
5.2 Global Vitamin K Antagonists (VKA) Revenue by Application
5.2.1 Global Vitamin K Antagonists (VKA) Historical Revenue by Application (2017-2022)
5.2.2 Global Vitamin K Antagonists (VKA) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2028)
5.3 Global Vitamin K Antagonists (VKA) Price by Application
5.3.1 Global Vitamin K Antagonists (VKA) Price by Application (2017-2022)
5.3.2 Global Vitamin K Antagonists (VKA) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vitamin K Antagonists (VKA) Market Size by Type
6.1.1 North America Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
6.1.2 North America Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
6.2 North America Vitamin K Antagonists (VKA) Market Size by Application
6.2.1 North America Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
6.2.2 North America Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
6.3 North America Vitamin K Antagonists (VKA) Market Size by Country
6.3.1 North America Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
6.3.2 North America Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vitamin K Antagonists (VKA) Market Size by Type
7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
7.2 Europe Vitamin K Antagonists (VKA) Market Size by Application
7.2.1 Europe Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
7.2.2 Europe Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
7.3 Europe Vitamin K Antagonists (VKA) Market Size by Country
7.3.1 Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
7.3.2 Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Type
8.1.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
8.1.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
8.2 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Application
8.2.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
8.2.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
8.3 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Region
8.3.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2017-2028)
8.3.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vitamin K Antagonists (VKA) Market Size by Type
9.1.1 Latin America Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
9.1.2 Latin America Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
9.2 Latin America Vitamin K Antagonists (VKA) Market Size by Application
9.2.1 Latin America Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
9.2.2 Latin America Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
9.3 Latin America Vitamin K Antagonists (VKA) Market Size by Country
9.3.1 Latin America Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
9.3.2 Latin America Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Type
10.1.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Type (2017-2028)
10.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Application
10.2.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Application (2017-2028)
10.3 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Country
10.3.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Corporation Information
11.5.2 Genentech (Roche) Overview
11.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Genentech (Roche) Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Lilly
11.7.1 Lilly Corporation Information
11.7.2 Lilly Overview
11.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lilly Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lilly Recent Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Corporation Information
11.8.2 Daiichi Sankyo Overview
11.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Daiichi Sankyo Recent Developments
11.9 Otsuka
11.9.1 Otsuka Corporation Information
11.9.2 Otsuka Overview
11.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Otsuka Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Otsuka Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Pfizer
11.11.1 Pfizer Corporation Information
11.11.2 Pfizer Overview
11.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pfizer Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Recent Developments
11.12 Aspen
11.12.1 Aspen Corporation Information
11.12.2 Aspen Overview
11.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aspen Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aspen Recent Developments
11.13 The Medicines Company
11.13.1 The Medicines Company Corporation Information
11.13.2 The Medicines Company Overview
11.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 The Medicines Company Vitamin K Antagonists (VKA) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 The Medicines Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vitamin K Antagonists (VKA) Industry Chain Analysis
12.2 Vitamin K Antagonists (VKA) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vitamin K Antagonists (VKA) Production Mode & Process
12.4 Vitamin K Antagonists (VKA) Sales and Marketing
12.4.1 Vitamin K Antagonists (VKA) Sales Channels
12.4.2 Vitamin K Antagonists (VKA) Distributors
12.5 Vitamin K Antagonists (VKA) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vitamin K Antagonists (VKA) Industry Trends
13.2 Vitamin K Antagonists (VKA) Market Drivers
13.3 Vitamin K Antagonists (VKA) Market Challenges
13.4 Vitamin K Antagonists (VKA) Market Restraints
14 Key Findings in The Global Vitamin K Antagonists (VKA) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer